Document is current
Any future updates will be listed below
-
Authors
Corbett, Jennifer M.
Hawthorne, Ian
Dunbar, Hazel
Coulter, Ivan
Chonghaile, Mairead Ni
Flynn, Catherine M.
English, Karen https://orcid.org/0000-0002-7932-4256
-
Funding
Funding for this research was provided by:
Irish Research Council (EPSPG/2012/467)
FP7 People: Marie-Curie Actions (321697)
Health Research Board (PDTM/2011/21)
- License Information
-
More Information
Article History
Received: 20 November 2020
Accepted: 25 March 2021
First Online: 14 April 2021
Declarations
:
: All procedures involving the use of animals or human materials were carried out by licenced personnel. Ethical approval for all work was granted by the biological research ethics committee of Maynooth University (BRESC-2013-13) and by the research ethics committee at St. James’s Hospital (2012/11/05). Human bone marrow aspirate was harvested from healthy adult donors under informed consent.
: This manuscript does not contain any individual person’s data in any form.
: IC is the named inventor of the SmPill® technology and SmPill®-enabled Cyclosporine A products, is the founder of Sigmoid Pharma Limited (renamed Sublimity Therapeutics) and remains a shareholder in Sublimity. JC was funded under an Irish Research Council Enterprise Partnership Scheme Scholarship part funded by Sigmoid Pharma. IH, HD, MNC and CMF declare that they have no competing interests. KE is an Associate Editor for Stem Cell Research & Therapy, but was not involved in the peer review process of this article.
